•
Jun 30, 2016

ResMed Q4 2016 Earnings Report

Total Revenue
$519M
Previous year: $453M
+14.5%
EPS
$0.74
Previous year: $0.68
+8.8%
Gross Profit
$301M
Previous year: $259M
+16.2%
Cash and Equivalents
$731M
Previous year: $717M
+2.0%
Free Cash Flow
$534M
Total Assets
$3.26B
Previous year: $2.18B
+49.3%

ResMed

ResMed